ARTICLE | Company News
KaloBios, Ludwig Institute for Cancer Research deal
July 26, 2004 7:00 AM UTC
KaloBios received an exclusive license from the institute to an antibody to treat autoimmune diseases. KaloBios plans to begin trials in rheumatoid arthritis (RA) patients in the second half of 2005. ...